The Unbiased Estimator

In today's episode, we talk with Dan Gorenstein about his experiences in health policy reporting and his podcast, Tradeoffs.Dan Gorenstein is the Founder, Executive Editor, and Host of Tradeoffs. Dan has extensive experience reporting on the business of healthcare. Prior to Tradeoffs, Dan served as the senior reporter for Marketplace's Health Desk, spent more than 11 years at New Hampshire Public Radio, and began his career as a journalist at the Chicago Reporter. Join our conversation with him about reporting on the world of health policy through grey-colored glasses! More information and references for this episode can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPodThe Unbiased Estimator is a production of the Duke Med Econ Interest Group. Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

In today's episode, Claudio Lucarelli advocates for more nuance in cost-effectiveness measures.Lucarelli is an Associate Professor of Health Care Management at The Wharton School and a Senior Fellow at the Leonard Davis Institute for Health Economics at the University of Pennsylvania. He studies the importance of heterogeneity in preferences in the construction of the measurements we use to decide if a medication is worth its cost. Join our conversation with him about cost-effectiveness and heterogeneity!More information and references for this episode can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPodThe Unbiased Estimator is a production of the Duke Med Econ Interest Group. Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

In today's episode, we discuss what price transparency and hospital disclosures of prices tell us about hospital pricing. Our guest is Ge Bai, Professor of Accounting at Johns Hopkins Carey Business School and Professor of Health Policy & Management at Johns Hopkins Bloomberg School of Public Health. Bai is fascinated by money and time. Through the lens of accounting, she is an expert in healthcare finance and policy. Today we talk about what the Hospital Price Transparency Final Rule and hospital disclosures about prices tell us about the healthcare market and how it still fails to manage high healthcare costs. More information and references for this episode can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPodThe Unbiased Estimator is a production of the Duke Med Econ Interest Group. Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

In today's episode, we discuss the impacts of litigation and prior authorization on the use of ambulances as taxis in the dialysis industry.My guest is Riley League, a Ph.D. candidate in Duke's Economics department. Riley works with Professor Roberts, the Department Chair of the Economics Department at Duke and has worked on several projects related to the dialysis industry. I'm excited to learn from him about the convoluted world of the dialysis industry and how he and his coauthors are untangling its effect on patients and healthcare costs.More information and the references for this show can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPod The Unbiased Estimator is a production of the Duke Med Econ Interest Group.  Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

In today's episode, we discuss how the acquisition of hospitals by private equity firms impacts the services they provide.My guest is Dr. Marcelo Cerullo, a general surgery resident at Duke Hospital. Dr. Cerullo received his undergrad degree at Harvard College and completed medical school at Johns Hopkins. I'm especially excited to speak with him today because of his dual role as a physician and a researcher in the field of health economics. More information and the references for this show can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPod The Unbiased Estimator is a production of the Duke Med Econ Interest Group.  Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

In today's episode, we discuss drug launch prices and how they are impacted by the way that Medicare reimburses providers for them. My guest is Professor David Ridley, faculty director for Health Sector Management at Duke University's Fuqua School of Business. He was the lead author of a paper that proposed the priority review voucher program, which became law in 2007 and created a market of over one billion dollars for drug development for neglected diseases.More information and the references for this show can be found here.WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPod The Unbiased Estimator is a production of the Duke Med Econ Interest Group.  Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.

Welcome to the Unbiased Estimator! How do we know what we know about healthcare? In each episode, we go on a hunt for the unbiased estimator, a treasure many economists seek that captures the effect of a policy or intervention. Speaking with expert researchers and physicians, we learn how the toolbox of economics can help untangle the complex world of healthcare. WebsiteEmail: unbiased.est@gmail.comTwitter: @UnbiasedEstPod The Unbiased Estimator is a production of the Duke Med Econ Interest Group.  Host @DanWangMed. Co-host and Mixed by @iAnkitChoudhury. Music by Coma-Media from Pixabay.